Xigris Infusion
Drotrecogin alfa
20mg
LILLY PHARMA FERTIGUNG UND DISTRIBUTION, GmbH & CO.
| Pack size | 1 Vial (Dry) |
|---|---|
| Dispensing mode | POM |
| Source | GERMANY |
| Agent | PHARMATRADE |
| Retail Price | 3916.50 AED |
Available as:
Indications
Xigris Infusion is used for:
For reduction of mortality in patients with severe sepsis.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Drotrecogin alfa :
Mechanism of Action
Activated protein C combines with protein S on platelet surfaces and then degrades factor Va and factor VIIIa, thereby reducing blood coagulability.
Note
Xigris 20mg Infusion manufactured by LILLY PHARMA FERTIGUNG UND DISTRIBUTION, GmbH & CO.. Its generic name is Drotrecogin alfa. Xigris is availble in United Arab Emirates.
Farmaco UAE drug index information on Xigris Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.